RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 66 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $3,826,672 | 56.07% |
| BML Capital Management, LLC | 2,672,194 | $4,035,013 | 2.88% |
| Aldebaran Capital, LLC | 447,616 | $675,900 | 0.63% |
| Aisling Capital Management LP | 886,075 | $1,337,973 | 0.58% |
| NEA Management Company, LLC | 4,785,494 | $7,226,096 | 0.54% |
| Octagon Capital Advisors LP | 2,250,000 | $3,397,500 | 0.53% |
| TANG CAPITAL MANAGEMENT LLC | 2,996,260 | $4,524,353 | 0.46% |
| Carlyle Group Inc. | 2,698,957 | $4,156,394 | 0.40% |
| Acuitas Investments, LLC | 406,209 | $613,376 | 0.33% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,915,376 | $4,402,218 | 0.14% |